Can a Ray of Sunshine Help the Critically Ill?

TAU researcher finds that vitamin D deficiency is associated with increased mortality in intensive care patients

 

Tel Aviv, Israel (April 3, 2012) – Scientists have long believed that vitamin D, which is naturally absorbed from sunlight, has an important role in the functioning of the body’s autoimmune system. Now Prof. Howard Amital of Tel Aviv University’s Sackler Faculty of Medicine and Sheba Medical Center has discovered that the vitamin may also affect the outcomes of patients in intensive care.

 

In a six-month study, Prof. Amital and his colleagues found that patients who had a vitamin D deficiency lived an average of 8.9 days less than those who were found to have sufficient vitamin D. Vitamin D levels also correlated with the level of white blood cells which fight disease.

 

The study, which was published in the journal QJM: An International Journal of Medicine, demonstrates further research into giving patients vitamin D could confirm that it will improve their survival outcomes.

 

 

Adding days of life

 

To measure the impact of vitamin D levels on the survival of critically ill patients, the researchers designed an observational study. Over the course of six months, 130 patients over the age of 18 admitted to an intensive care unit of a TAU-affiliated hospital and requiring mechanical ventilation were admitted to the study. Patients who had taken vitamin D supplements prior to admittance were excluded from the study population.

 

Upon admittance, patients were divided into two groups based on vitamin D concentration: those who had 20 nanograms or more of the vitamin — the amount defined as the National Institute of Health as sufficient — and those who were vitamin D deficient based on the same criteria. In total, 107 patients suffered from vitamin D deficiency.

 

Survival curves indicate that while patients with sufficient vitamin D survived an average of 24.2 days, those who were deemed to be deficient in vitamin D survived an average of only 15.3 days — patients with sufficient vitamin D levels survived an average of 8.9 days longer. They were also found to have a better WBC count.

 

 

Seek out sun — or supplements

 

These findings merit further investigation, Prof. Amital says. He suggests that the effects of vitamin D supplementation in critically ill patients be further assessed in future studies. The initial results indicate only that vitamin D concentration may be an indicator of survival, he says.

 

But don’t wait until you’re in poor health to start taking vitamin D, suggests Prof. Amital. Vitamin D appears to enhance the function of the immune system in numerous ways, and it’s becoming clear that it does have an impact on overall health and well-being.

 

According to research, including an article in the New England Journal of Medicine, the majority of those who live in North America and other Western countries are known to be vitamin D deficient due to limited exposure to the sun. But even if the springtime skies are gray, supplements from the pharmacy shelf will have the same benefits, Prof. Amital says.

 

For more diet and nutrition health news from Tel Aviv University: http://www.aftau.org/site/PageServer?pagename=newsroom_newsarticles_categories_3#diet

 


 

Tel Aviv University Sackler Faculty of Medicine and Sheba Medical Center, 03.04.2012 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung